MYNZ logo

Mainz Biomed BV (MYNZ)

Profile

Full Name

Mainz Biomed N.V.

Ticker Symbol

MYNZ

Exchange

NASDAQ

Country

Germany

IPO

November 5, 2021

Indexes

Not included

Employees

19

Key Details

Price

$3.37(+1.20%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$894.00K(-0.17% YoY)

Annual EPS

-$22.36(+65.47% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Feb 14, 25 Maxim Group
Buy
Nov 25, 24 HC Wainwright & Co.
Neutral
Apr 12, 24 Cantor Fitzgerald
Neutral
Mar 6, 24 HC Wainwright & Co.
Buy
Nov 21, 23 Cantor Fitzgerald
Neutral
Nov 20, 23 HC Wainwright & Co.
Buy
Sep 26, 23 Cantor Fitzgerald
Overweight
Sep 22, 23 HC Wainwright & Co.
Buy
Sep 14, 23 Cantor Fitzgerald
Overweight
Aug 22, 23 Cantor Fitzgerald
Overweight

Institutional Ownership

  • What is the ticker symbol for Mainz Biomed BV?
  • Does Mainz Biomed BV pay dividends?
  • What sector is Mainz Biomed BV in?
  • What industry is Mainz Biomed BV in?
  • What country is Mainz Biomed BV based in?
  • When did Mainz Biomed BV go public?
  • Is Mainz Biomed BV in the S&P 500?
  • Is Mainz Biomed BV in the NASDAQ 100?
  • Is Mainz Biomed BV in the Dow Jones?
  • When was Mainz Biomed BV's last earnings report?
  • When does Mainz Biomed BV report earnings?
  • Should I buy Mainz Biomed BV stock now?

What is the ticker symbol for Mainz Biomed BV?

The ticker symbol for Mainz Biomed BV is NASDAQ:MYNZ

Does Mainz Biomed BV pay dividends?

No, Mainz Biomed BV does not pay dividends

What sector is Mainz Biomed BV in?

Mainz Biomed BV is in the Healthcare sector

What industry is Mainz Biomed BV in?

Mainz Biomed BV is in the Diagnostics & Research industry

What country is Mainz Biomed BV based in?

Mainz Biomed BV is headquartered in Germany

When did Mainz Biomed BV go public?

Mainz Biomed BV's initial public offering (IPO) was on November 5, 2021

Is Mainz Biomed BV in the S&P 500?

No, Mainz Biomed BV is not included in the S&P 500 index

Is Mainz Biomed BV in the NASDAQ 100?

No, Mainz Biomed BV is not included in the NASDAQ 100 index

Is Mainz Biomed BV in the Dow Jones?

No, Mainz Biomed BV is not included in the Dow Jones index

When was Mainz Biomed BV's last earnings report?

Mainz Biomed BV's most recent earnings report was on Apr 1, 2025

When does Mainz Biomed BV report earnings?

The next expected earnings date for Mainz Biomed BV is May 15, 2025

Should I buy Mainz Biomed BV stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page